{"id":963781,"date":"2026-05-15T19:05:11","date_gmt":"2026-05-15T23:05:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/"},"modified":"2026-05-15T19:05:11","modified_gmt":"2026-05-15T23:05:11","slug":"biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/","title":{"rendered":"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Biogen shares dropped 6.4% after Phase 2 CELIA trial data revealed information absent from the Company’s filings.<\/i>\n <\/p>\n

\n NEW YORK<\/span>, May 15, 2026<\/span> \/PRNewswire\/ — Biogen Inc. (NASDAQ: BIIB) investors lost approximately 6.4% per share on May 14, 2026, after Phase 2 “CELIA” topline data for diranersen missed its primary dose-response endpoint. Shareholders who lost money on BIIB are encouraged to submit their information to Levi & Korsinsky<\/a>. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com<\/a> or by telephone at (212) 363-7500.<\/p>\n

\n

\n
\n \"Levi
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Biogen published a press release on May 14, 2026, announcing that CELIA did not meet its primary endpoint assessing dose response;. The Company further stated that based on the strength of the biomarker and efficacy data, Biogen plans to advance diranersen to registrational development anyway.<\/p>\n

If you purchased Biogen shares and suffered a loss, click here to discuss your legal rights with Levi & Korsinsky<\/a>. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com<\/a> or by telephone at (212) 363-7500.<\/p>\n

Levi & Korsinsky, LLP — Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.<\/p>\n

Frequently Asked Questions About the BIIB Investigation<\/p>\n

\n Q: Who is eligible to participate in the BIIB investigation?<\/b>A: Investors who purchased BIIB stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.<\/p>\n

\n Q: Which statements are being investigated as potentially misleading?<\/b>A: The investigation concerns whether Biogen made materially false or misleading statements regarding the failure of CELIA to meet its primary endpoint. When the Phase 2 CELIA data became public, the stock price declined sharply.<\/p>\n

\n Q: How much did BIIB stock drop?<\/b>A: Shares fell approximately 6.4% on May 14, 2026, after the Company released Phase 2 CELIA topline data for diranersen showing the trial failed to meet its primary dose-response endpoint.<\/p>\n

\n Q: What do BIIB investors need to do right now?<\/b>A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com<\/a> or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.<\/p>\n

\n Q: What happens after I contact Levi & Korsinsky?<\/b>A: An attorney will review your trading history at no cost and provide an initial assessment of your potential recovery.<\/p>\n

\n Q: What does it cost me to participate?<\/b>A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.<\/p>\n

\n Q: What if I already sold my BIIB shares — can I still recover losses?<\/b>A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought BIIB and sold at a loss may still participate in the investigation.<\/p>\n

CONTACT:\\<\/p>\n

Levi & Korsinsky, LLP\\<\/p>\n

Joseph E. Levi, Esq.\\<\/p>\n

Ed Korsinsky, Esq.\\<\/p>\n

33 Whitehall Street, 27th Floor\\<\/p>\n

New York, NY 10004\\<\/p>\n

\n jlevi@levikorsinsky.com<\/a>\\<\/p>\n

Tel: (212) 363-7500\\<\/p>\n

Fax: (212) 363-7171<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/biogen-inc-investigation-initiated-levi–korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib-302773905.html<\/a><\/p>\n

SOURCE Levi & Korsinsky, LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire Biogen shares dropped 6.4% after Phase 2 CELIA trial data revealed information absent from the Company’s filings. NEW YORK, May 15, 2026 \/PRNewswire\/ — Biogen Inc. (NASDAQ: BIIB) investors lost approximately 6.4% per share on May 14, 2026, after Phase 2 “CELIA” topline data for diranersen missed its primary dose-response endpoint. Shareholders who lost money on BIIB are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. Biogen published a press release on May 14, 2026, announcing that CELIA did not meet its primary endpoint assessing dose response;. The Company further stated that based on the strength of the biomarker … <\/p>\n

Continue reading “Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-963781","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBiogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Biogen shares dropped 6.4% after Phase 2 CELIA trial data revealed information absent from the Company’s filings. NEW YORK, May 15, 2026 \/PRNewswire\/ — Biogen Inc. (NASDAQ: BIIB) investors lost approximately 6.4% per share on May 14, 2026, after Phase 2 “CELIA” topline data for diranersen missed its primary dose-response endpoint. Shareholders who lost money on BIIB are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. Biogen published a press release on May 14, 2026, announcing that CELIA did not meet its primary endpoint assessing dose response;. The Company further stated that based on the strength of the biomarker … Continue reading "Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-15T23:05:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)\",\"datePublished\":\"2026-05-15T23:05:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/\"},\"wordCount\":523,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/\",\"name\":\"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"datePublished\":\"2026-05-15T23:05:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/","og_locale":"en_US","og_type":"article","og_title":"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) - Market Newsdesk","og_description":"PR Newswire Biogen shares dropped 6.4% after Phase 2 CELIA trial data revealed information absent from the Company’s filings. NEW YORK, May 15, 2026 \/PRNewswire\/ — Biogen Inc. (NASDAQ: BIIB) investors lost approximately 6.4% per share on May 14, 2026, after Phase 2 “CELIA” topline data for diranersen missed its primary dose-response endpoint. Shareholders who lost money on BIIB are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. Biogen published a press release on May 14, 2026, announcing that CELIA did not meet its primary endpoint assessing dose response;. The Company further stated that based on the strength of the biomarker … Continue reading \"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-15T23:05:11+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)","datePublished":"2026-05-15T23:05:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/"},"wordCount":523,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/","name":"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","datePublished":"2026-05-15T23:05:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biogen-inc-investigation-initiated-levi-korsinsky-investigates-the-officers-and-directors-of-biogen-inc-biib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/963781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=963781"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/963781\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=963781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=963781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=963781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}